Order Article Reprints

Al-Ezzi EM, Zahralliyali A, Hansen AR, Hamilton RJ, Crump M, Kuruvilla J, Wood L, Nappi L, Kollmannsberger CK, North SA, et al. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. Current Oncology. 2023; 30(7):6166-6176. https://doi.org/10.3390/curroncol30070458

Al-Ezzi, Esmail M., Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, and et al. 2023. "The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey" Current Oncology 30, no. 7: 6166-6176. https://doi.org/10.3390/curroncol30070458

Al-Ezzi, E. M., Zahralliyali, A., Hansen, A. R., Hamilton, R. J., Crump, M., Kuruvilla, J., Wood, L., Nappi, L., Kollmannsberger, C. K., North, S. A., Winquist, E., Soulières, D., Hotte, S. J., & Jiang, D. M. (2023). The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. Current Oncology, 30(7), 6166-6176. https://doi.org/10.3390/curroncol30070458